New Ray Medicine International Holding Limited (HKG:6108)
Hong Kong
· Delayed Price · Currency is HKD 0.200
0.00 (0.00%)
At close: Apr 29, 2026
HKG:6108 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 130.37 | 93.95 | 50.15 | 89.77 | 335.38 | Upgrade
|
| Revenue Growth (YoY) | 38.78% | 87.31% | -44.13% | -73.23% | 151.76% | Upgrade
|
| Cost of Revenue | 114.23 | 95.57 | 38.81 | 118.96 | 306.89 | Upgrade
|
| Gross Profit | 16.15 | -1.62 | 11.34 | -29.18 | 28.49 | Upgrade
|
| Selling, General & Admin | 24.57 | 30.6 | 28.7 | 39.61 | 30.92 | Upgrade
|
| Operating Expenses | 32.45 | 36.31 | 32.76 | 44.23 | 35.57 | Upgrade
|
| Operating Income | -16.3 | -37.94 | -21.42 | -73.42 | -7.08 | Upgrade
|
| Interest Expense | -0.14 | -0.1 | -0.03 | -0.18 | -0.28 | Upgrade
|
| Interest & Investment Income | 0.69 | 2.53 | 3.68 | 3.37 | 1.3 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | 1.11 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.13 | -0.67 | -0.57 | -10.63 | 4.25 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | 0.05 | -2.11 | 0.07 | 0.09 | Upgrade
|
| EBT Excluding Unusual Items | -15.88 | -36.13 | -20.45 | -80.79 | -0.62 | Upgrade
|
| Gain (Loss) on Sale of Investments | -4.18 | 3.93 | 0.42 | - | -2.99 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.12 | 0.14 | 0.48 | 0.38 | -0.01 | Upgrade
|
| Asset Writedown | - | - | -2.8 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | 0.12 | - | Upgrade
|
| Pretax Income | -19.94 | -32.06 | -22.34 | -80.29 | -3.61 | Upgrade
|
| Income Tax Expense | 0.13 | -1.05 | -0.17 | -2.34 | -0.78 | Upgrade
|
| Net Income | -20.07 | -31.01 | -22.17 | -77.95 | -2.82 | Upgrade
|
| Net Income to Common | -20.07 | -31.01 | -22.17 | -77.95 | -2.82 | Upgrade
|
| Shares Outstanding (Basic) | 168 | 167 | 167 | 167 | 167 | Upgrade
|
| Shares Outstanding (Diluted) | 168 | 167 | 167 | 167 | 167 | Upgrade
|
| Shares Change (YoY) | 0.49% | - | - | - | - | Upgrade
|
| EPS (Basic) | -0.12 | -0.19 | -0.13 | -0.47 | -0.02 | Upgrade
|
| EPS (Diluted) | -0.12 | -0.19 | -0.13 | -0.47 | -0.02 | Upgrade
|
| Free Cash Flow | - | -5.39 | -45.45 | -9.02 | -58.45 | Upgrade
|
| Free Cash Flow Per Share | - | -0.03 | -0.27 | -0.05 | -0.35 | Upgrade
|
| Gross Margin | 12.39% | -1.73% | 22.61% | -32.51% | 8.49% | Upgrade
|
| Operating Margin | -12.50% | -40.38% | -42.71% | -81.78% | -2.11% | Upgrade
|
| Profit Margin | -15.39% | -33.01% | -44.20% | -86.83% | -0.84% | Upgrade
|
| Free Cash Flow Margin | - | -5.73% | -90.62% | -10.04% | -17.43% | Upgrade
|
| EBITDA | -14.6 | -36.23 | -16.63 | -68.46 | -2.86 | Upgrade
|
| EBITDA Margin | -11.20% | -38.57% | -33.15% | -76.27% | -0.85% | Upgrade
|
| D&A For EBITDA | 1.7 | 1.7 | 4.8 | 4.95 | 4.22 | Upgrade
|
| EBIT | -16.3 | -37.94 | -21.42 | -73.42 | -7.08 | Upgrade
|
| EBIT Margin | -12.50% | -40.38% | -42.71% | -81.78% | -2.11% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.